(Q41474129)

1 October 2017

1 reference

title

Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients: Part 2. (English)

1 reference

1 October 2017

Heylen R

1

1 reference

1 October 2017

Miller R

series ordinal

2

1 reference

1 October 2017

1 February 1997

1 reference

1 October 2017

Genitourinary medicine

1 reference

1 October 2017

73

1 reference

1 October 2017

1

1 reference

1 October 2017

5-11

1 reference

Renal failure after treatment with ritonavir

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195751

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195751

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195751

Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195751

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195751

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195751

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195751

The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1195751

A preliminary trial of lamivudine for chronic hepatitis B infection

11 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9155547

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9155547

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

1 October 2017

PubMed publication ID

9155547

1 reference